Fibroblast growth factors in Alzheimer’s Disease pathogenesis: neuropharmacological implications for neuroprotection, neurogenesis, and therapeutic development

Jahnvi Sehgal, Kajal Bagri, Rahul Deshmukh

Open source

DOI
10.1007/s11033-026-12698-7
Published
2026-09-03
Container
Molecular Biology Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11033-026-12698-7,
  title = {Fibroblast growth factors in Alzheimer’s Disease pathogenesis: neuropharmacological implications for neuroprotection, neurogenesis, and therapeutic development},
  author = {Jahnvi Sehgal and Kajal Bagri and Rahul Deshmukh},
  year = {2026},
  journal = {Molecular Biology Reports},
  doi = {10.1007/s11033-026-12698-7},
  url = {https://doi.org/10.1007/s11033-026-12698-7}
}

RIS

TY  - JOUR
TI  - Fibroblast growth factors in Alzheimer’s Disease pathogenesis: neuropharmacological implications for neuroprotection, neurogenesis, and therapeutic development
AU  - Jahnvi Sehgal
AU  - Kajal Bagri
AU  - Rahul Deshmukh
PY  - 2026
JO  - Molecular Biology Reports
DO  - 10.1007/s11033-026-12698-7
UR  - https://doi.org/10.1007/s11033-026-12698-7
ER  - 

APA

Sehgal, J., Bagri, K., & Deshmukh, R. (2026). Fibroblast growth factors in Alzheimer’s Disease pathogenesis: neuropharmacological implications for neuroprotection, neurogenesis, and therapeutic development. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-12698-7

Source records